Your browser doesn't support javascript.
loading
Genetic Backgrounds Associated With Stent Thrombosis: A Pilot Study From a Percutaneous Coronary Intervention Registry.
Shoji, Satoshi; Sawano, Mitsuaki; Inohara, Taku; Hiraide, Takahiro; Ueda, Ikuko; Suzuki, Masahiro; Noma, Shigetaka; Fukuda, Keiichi; Kohsaka, Shun.
Afiliação
  • Shoji S; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
  • Sawano M; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
  • Inohara T; Section of Cardiovascular Medicine, Department of Internal Medicine, Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Connecticut, USA.
  • Hiraide T; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
  • Ueda I; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
  • Suzuki M; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
  • Noma S; Department of Cardiology, National Hospital Organization Saitama Hospital, Saitama, Japan.
  • Fukuda K; Department of Cardiology, Saiseikai Utsunomiya Hospital, Tochigi, Japan.
  • Kohsaka S; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
JACC Adv ; 2(1): 100172, 2023 Jan.
Article em En | MEDLINE | ID: mdl-38939036
ABSTRACT

Background:

Stent thrombosis (ST) is a rare, yet devastating, complication following percutaneous coronary intervention (PCI), with poorly understood pathophysiologic characteristics and genetic backgrounds.

Objectives:

The authors performed a genome-wide association study to identify the common genetic loci associated with early stent thrombosis (EST) and late/very late ST (LST/VLST) in a contemporary Japanese multicenter PCI registry.

Methods:

Among 8,642 PCI patients included in the registry, 42 who experienced stent thrombosis [EST (n = 15) and LST/VLST (n = 27)] were included (mean age, 67.6 ± 10.8 years; and 88.1% men). We conducted a genome-wide association study using the BioBank Japan patient population as the control (control #1 acute coronary syndrome [n = 29,542] and control #2 effort angina [n = 8,900]) to identify significant single nucleotide polymorphisms (SNPs) and evaluate the performance of polygenic risk scores (PRSs) for predicting these conditions.

Results:

We compared patients with EST with controls #1 and #2 and identified SNPs (rs565401593 and rs561634568) in NSD1, and patients with LST/VLST with controls #1 and #2 and identified SNPs (rs532623294 and rs199546342) in GRIN2A. PRS for LST/VLST showed high predictive performance (area under the curve 0.83 [95% CI 0.76-0.89] and 0.83 [95% CI 0.77-0.89]), whereas PRS for EST showed modest predictive performance (area under the curve 0.71 [95% CI 0.58-0.85] and 0.72 [95% CI 0.58-0.85]).

Conclusions:

We identified different genetic predispositions between EST and LST/VLST and demonstrated that the incorporation of PRS may aid in risk prediction of this highly fatal event.
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: JACC Adv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: JACC Adv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão